news
A global threat heightened by Covid-19
The New Nation
photo by
Catherine Boudot
The latest report from the European Union Intellectual Property Office (EUIPO) and the Organisation for Economic Co-operation and Development (OECD) highlights the dangers of counterfeit medicines for patients as well as the challenges posed by this form of illicit trade for governments and health care companies. The trend has only been exacerbated by the current health emergency created by Covid-19, with people worried about how to deal with this new unknown danger, which still has no approved vaccine or treatment, and the spread of potentially harmful fake products and medicines.